Skip to content

A clinical evaluation of the effect of haptic cane use on gait in individuals with chronic stroke

A randomized, single-center, single blind, a clinical trial to evaluate the effect on gait performance of gait training with/without haptic cane (orthosis) in chronic stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0011309
Enrollment
20
Registered
2025-12-11
Start date
2024-09-05
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : A total of 20 participants will be randomly assigned to the haptic cane gait training group (n=10) or the conventional gait training group (n=10), and, according to the crossover desi

Sponsors

Chonnam National University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: -Aged 20 to 90 years -Chronic stroke patients at least 3 months after onset -Unilateral hemiparesis -Functional Ambulation Category (FAC) levels 2–4 -Patients who can follow the therapist’s instructions for gait training -Patients who agree to participate in the study

Exclusion criteria

Exclusion criteria: -Presence of gait or balance disorders caused by diseases other than stroke (e.g., gait abnormalities due to Parkinson’s disease, peripheral neuropathy, myopathy, arthropathy) -History of epileptic seizures or current treatment for epilepsy -Use of medications, procedures, or surgeries within the past month that may affect gait training -Unstable vital signs -Ongoing treatment for malignant diseases -Severe depression or psychiatric disorders that may interfere with treatment compliance -Severe aphasia that prevents effective communication -Cognitive impairment that prevents understanding of instructions (Clinical Dementia Rating, CDR = 1) -Receiving other treatments during the study period that may affect gait function (e.g., patients who received botulinum toxin injections or joint replacement surgery) -Confirmed pregnancy or currently breastfeeding -Participation in another clinical study -Inability to understand the purpose of the study or comply with study-related procedures -Any other condition that, in the investigator’s judgment, makes participation in the clinical trial inappropriate

Design outcomes

Primary

MeasureTime frame
10 meter walking test

Secondary

MeasureTime frame
MMT(Manual Muscle Test);TUG(Timed Up and Go test);FAC(Functional Ambulation Category;BBS(Berg Balance Scale);K-MBI(K-Modified Barthel Index);EQ-5D-3L;Gait analysis

Countries

Korea, Republic of

Contacts

Public ContactHae-Young YU

Chonnam National University Hospital

154kg@naver.com+82-62-220-5186

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026